CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.

News Chongqing Zhifei Biological Products Co., Ltd.

Equities

300122

CNE100000V20

End-of-day quote Shenzhen Stock Exchange Other stock markets 06:00:00 2023-09-27 pm EDT			5-day change	1st Jan Change
48.67 ^CNY	-0.37%		-0.73%	-16.88%

Aug. 29	Zhifei Biological Products’ H1 Profit Rises 14% as Revenue Jumps 33%	MT
Aug. 28	Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Summary

Zhifei Biological Products’ H1 Profit Rises 14% as Revenue Jumps 33%	Aug. 29	MT
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	Aug. 28	CI
EVE Energy Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 16 June 2023	Jun. 12	CI
Chongqing Zhifei Biological Products Co., Ltd Approves the Cash Dividend	Apr. 21	CI
Zhifei Biological Products’ Profit Rises 6% as Revenue Jumps 26%	Apr. 20	MT
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	Apr. 19	CI
Chongqing Zhifei Biological Products Co., Ltd. Proposes Final Cash Dividend for 2022	Mar. 20	CI
Zhifei Biological Products Renews Supply Deal With Merck	Jan. 29	MT
Chongqing Zhifei Biological's Shares Surge After Rollout of 2nd-Generation COVID-19 Vaccine	Nov. 10	MT
Zhifei Biological Posts 36% Rise in Q3 Profit	2022	MT
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	2022	CI
Zhifei Biological's H1 Profit Tanks 32% as Costs Outweigh Revenue	2022	MT
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	2022	CI
Chongqing Zhifei Biological Products Co., Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on July 15, 2022	2022	CI
Some Omicron sub-variants escaping antibodies from Sinopharm shot -Chinese study	2022	RE
Chongqing Zhifei Biological Products Co., Ltd. Approves Cash Dividend for the Year 2021	2022	CI
UBS Adjusts Chongqing Zhifei Biological Products' Price Target to 163 Yuan From 175 Yuan, Keeps at Buy	2022	MT
Zhifei Biological's Q1 Profit Surges 105% as Sales More Than Double	2022	MT
Chongqing Zhifei Biological Products Co., Ltd. Proposes Final Cash Dividend for the Year 2021	2022	CI
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	2022	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features

News Chongqing Zhifei Biological Products Co., Ltd.

Equities

300122

CNE100000V20

Summary

Filters